TASLY
LIVE

Serial Number

79418680

Owner

Tasly Pharmaceutical Group Co., Ltd.

Attorney

Zhi Dong

Filing Date

Aug 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TASLY Trademark

Serial Number: 79418680 • Registration: 8112887

TASLY is a trademark filed by Tasly Pharmaceutical Group Co., Ltd. on August 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Tasly Pharmaceutical Group Co., Ltd. (3 trademarks)

Tasly Modern TCM Garden,

Entity Type: 99

Trademark Details

Filing Date

August 16, 2024

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; herbs for medicinal purposes; medicines made of Chinese traditional medicinal herbs for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; capsules for medicines, namely, capsules sold empty for pharmaceuticals; pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; dietetic food and beverages adapted for medical use; bath preparations, medicated; medical analgesic preparations; preparations for the treatment of burns; syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; pharmaceutical gelatin, namely, gelatin capsules sold empty for pharmaceuticals; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils, other than essential oils; medicinal herbs; lotions for pharmaceutical purposes, namely, anti-bacterial hand wash, medicated oral rinse, gynecological vaginal wash for medical purposes, anorectal wash for medical purposes; ointments for pharmaceutical purposes, namely, sunburn ointments, anti-inflammatory ointments, hemorrhoidal ointments, frostbite salve for pharmaceutical purposes, eye ointments for medical use; pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxes, filled; medicinal roots; medicinal herbal preparations, namely, medicated tonics for treating cardiovascular disease, AMS, heart failure, cardiovascular and cerebrovascular disease; sedatives; soporifics; sugar for medical purposes; biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; weight-reducing aid, namely, weight management supplements; pharmaceutical preparations for the treatment of sunburns; food supplements, namely, antioxidants used for medicinal purposes; acne treatment preparation; medicinal herbal preparations, namely, lysine electuary for medicinal use; oral rehydration salts; medicinal liquor, namely, medicinal alcohol for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicinal herbal preparations, namely, ginseng electuary for medicinal use; ginseng for medicinal use; medicinal herbal preparations, namely, medlar; dietetic beverages adapted for medicinal purposes, namely, weight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, fruits; food for babies; milk powder for infants; air purifying preparations; medicated animal washes; veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS), diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets; raw material medicine, namely, pill, tablet, capsule, liquid drops, granule for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 11, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 28, 2025 TROA
REFUSAL PROCESSED BY IB
Jun 28, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 9, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 9, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 6, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 21, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 6, 2025 REPR